首页> 外文期刊>american journal of clinical and experimental urology >Performance characteristics of urinary cytology in patients presenting with gross and microscopic hematuria
【24h】

Performance characteristics of urinary cytology in patients presenting with gross and microscopic hematuria

机译:肉眼和显微镜下血尿患者尿细胞学检查的性能特征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose: Hematuria investigations presently entail cystoscopy with upper urinary tract imaging albeit without use of urinary biomarkers including cytology. The purpose is to investigate the performance characteristics of urinary cytology in a population of patients presenting with gross (GH) and microscopic (MH) hematuria. Methods: Records for 409 consecutive patients undergoing a complete hematuria evaluation (cystoscopy with upper-tract imaging) who also had urinary cytology were reviewed. Performance characteristics (sensitivity, specificity, PPV, NPV) of cytology for urothelial malignancy were determined. For those with urothelial cancer, the predictive value of a positive cytology for high grade and high stage urothelial cancer was determined. Results: 29 of 409 patients (7.1) were diagnosed with urothelial carcinoma including 24 (9.2) and 5 (3.4) from the GH and MH populations, respectively. Eighteen (62) of these tumors were high grade of which 5 (28) were muscle-invasive. The performance characteristics of cytology for urothelial malignancy included a sensitivity of 41, specificity of 99, PPV of 75, NPV of 96, and diagnostic accuracy of 95. No observed differences were noted when comparing gender (P=0.55), type of hematuria (P=0.37), or smoking history (P=0.22). For those diagnosed with urothelial malignancy, a positive cytology was not associated with higher grade (P=1.0) or stage tumors (P=0.62). Conclusions: Urine cytology had low sensitivity and PPV for urothelial carcinoma irrespective of smoker status, hematuria type, or gender. These data support the 2020 AUA Microhematuria Guideline emphasizing that urine cytology should not routinely be used in a hematuria screening population.
机译:目的:血尿检查目前需要膀胱镜检查和上尿路影像学检查,尽管不使用包括细胞学在内的尿液生物标志物。目的是研究尿细胞学检查在出现肉眼 (GH) 和显微镜 (MH) 血尿的患者群体中的表现特征。方法:对409例连续接受全血尿评估(膀胱镜检查和上尿路影像学检查)且同时进行尿细胞学检查的患者的记录进行回顾。确定尿路上皮恶性肿瘤细胞学的性能特征(敏感性、特异性、PPV、NPV)。对于尿路上皮癌患者,确定了高级别和高级别尿路上皮癌细胞学阳性的预测价值。结果:409例患者中有29例(7.1%)被诊断为尿路上皮癌,其中GH和MH人群分别24例(9.2%)和5例(3.4%)。这些肿瘤中有18例(62%)为高级别,其中5例(28%)为肌肉浸润性。尿路上皮恶性肿瘤细胞学的性能特征包括敏感性 41%、特异性 99%、PPV 75%、NPV 96% 和 95% 诊断准确率。在比较性别(P=0.55)、血尿类型(P=0.37)或吸烟史(P=0.22)时,未观察到差异。对于诊断为尿路上皮恶性肿瘤的患者,细胞学阳性与更高级别 (P=1.0) 或分期肿瘤 (P=0.62) 无关。结论:尿细胞学检查对尿路上皮癌的敏感性和PPV均较低,无论吸烟者身份、血尿类型或性别如何。这些数据支持 2020 年 AUA 微血尿指南,该指南强调尿液细胞学检查不应常规用于血尿筛查人群。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号